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Summary .  Proadrenomedullin (pADM)-derived 
peptides, adrenomedullin (ADM) and pADM N-terminal 
20 peptide (PAMP), are hypotensive peptides, which are 
expressed, along with their receptors, in several tissues 
and organs, the function of which they regulate by acting 
in an autocrine-paracrine manner. Apart from their 
involvement in the regulation of blood pressure and fluid 
and electrolyte homeostasis, pADM-derived peptides 
appear to play a role in the modulation of cell and tissue 
growth. Evidence has been provided that ADM: 1) 
favors the remodeling of cardiovascular system under 
pathological conditions, by exerting an antiapoptotic 
effect on endothelial cells and an antiproliferogenic and 
antimigratory action on vascular smooth-muscle cells 
during neointimal hyperplasia, and by decreasing 
proliferation and protein synthesis of cardiac myocytes 
and fibroblasts. These last two effects are mediated by 
calcitonin gene-related peptide type 1 ( C G R P l )  
receptors coupled to the adenylate cyclase (AC)/protein 
kinase (PK) A-dependent cascade; 2) inhibits 
proliferation and enhances apoptosis  of kidney 
mesangial cells, through the modulation of mitogen- 
activated PK (MAPK) cascades; 3) s t imulates  
proliferation of adrenal zona glomerulosa cells, acting 
via CGRPl receptor coupled to the tyrosine kinase- 
dependent MAPK cascade, thereby possibly being 
involved in the maintenance and stimulation of adrenal 
growth; 4) enhances proliferation of skin and mucosa 
epithelia1 cells and fibroblasts, by activating CGRPl 
receptor coupled to the ACIPKA signaling pathway; and 
5) enhances proliferation of several tumor-cell lines 
through the activation of the ACIPKA cascade, which 
suggests a potential role for ADM as  promoter of 
neoplastic growth. The growth effects of PAMP have 
been far less investigated: findings indicate that this 
peptide, like ADM, enhances adrenal zona glomerulosa- 
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cell proliferation, and, in contrast with ADM, depresses 
DNA synthesis in some cancer-cell lines. Both pADM- 
derived peptides are thought to  be involved in 
embryogenesis, such a contention being based on the 
demonstration of high pADM-gene expression during 
the crucial phases of organ growth and differentiation. 
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Introduction 
Adrenomedullin (ADM) is a potent hypotensive 
peptide, which was originally isolated from extracts of 
human pheochromocytomas (Kitamura et al., 1993). 
Subsequently, it was found that ADM is produced by the 
proteolytic cleavage of a prohormone, the 
prepro(pp)ADM, that also contains in its NH2 terminus a 
unique 20-amino acid residue sequence, exerting a 
transient hypotensive effect and named pro(p)ADM N- 
terminal 20 peptide (PAMP) (Kitamura et al., 1994). 
In the 7-8 years following their discovery, pADM- 
derived peptides were shown to be almost ubiquitously 
expressed in body organs and tissues, and to exert 
multiple important effects, among which are regulation 
of blood pressure and fluid and electrolyte homeostasis, 
and more recently of normal and neoplastic cell growth. 
Several review articles have been published on ADM 
and PAMP (Richards et al., 1996; Schell et al., 1996; 
Nussdorfer et al., 1997; Champion et al., 1999; Samson, 
1999; Hinson et al., 2000; Jougasaki and Burnett, 2000; 
Nussdorfer, 2001). However, none of them have focused 
specifically on the role of pADM-derived peptides such 
as cell growth regulators. 
After having briefly described the main biological 
characteristics of ADM and PAMP, we will summarize 
and discuss findings suggesting that these peptides play 
important roles in the modulation of cell growth and 
apoptosis in many normal and pathological tissues. 











